Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study

André Reimer, Andreas Schmitt, Dominic Ehrmann, Bernhard Kulzer, Norbert Hermanns, André Reimer, Andreas Schmitt, Dominic Ehrmann, Bernhard Kulzer, Norbert Hermanns

Abstract

Objective: Depressive symptoms in people with diabetes are associated with increased risk of adverse outcomes. Although successful psychosocial treatment options are available, little is known about factors that facilitate treatment response for depression in diabetes. This prospective study aims to examine the impact of known risk factors on improvement of depressive symptoms with a special interest in the role of diabetes-related distress.

Methods: 181 people with diabetes participated in a randomized controlled trial. Diabetes-related distress was assessed using the Problem Areas In Diabetes (PAID) scale; depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale. Multiple logistic and linear regression analyses were used to assess associations between risk factors for depression (independent variables) and improvement of depressive symptoms (dependent variable). Reliable change indices were established as criteria of meaningful reductions in diabetes distress and depressive symptoms.

Results: A reliable reduction of diabetes-related distress (15.43 points in the PAID) was significantly associated with fourfold increased odds for reliable improvement of depressive symptoms (OR = 4.25, 95% CI: 2.05-8.79; P<0.001). This result was corroborated using continuous measures of diabetes distress and depressive symptoms, showing that greater reduction of diabetes-related distress independently predicted greater improvement in depressive symptoms (ß = -0.40; P<0.001). Higher age had a positive (Odds Ratio = 2.04, 95% CI: 1.21-3.43; P<0.01) and type 2 diabetes had a negative effect on the meaningful reduction of depressive symptoms (Odds Ratio = 0.12, 95% CI: 0.04-0.35; P<0.001).

Conclusions: The reduction of diabetes distress is a statistical predictor of improvement of depressive symptoms. Diabetes patients with comorbid depressive symptomatology might benefit from treatments to reduce diabetes-related distress.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Odds ratios for the reliable…
Fig 1. Odds ratios for the reliable reduction of depressive symptoms.
**P<0.01; ***P<0.001.

References

    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis. Diabetes Care. 2001. June 1;24(6):1069–78.
    1. Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. Journal of Affective Disorders. 2012. October;142, Supplement:S8–21. doi:
    1. Lin EHB, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of Depression and Diabetes Self-Care, Medication Adherence, and Preventive Care. Diabetes Care. 2004. September 1;27(9):2154–60.
    1. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001. August;63(4):619–30.
    1. Lustman PJ, Clouse RE. Depression in diabetic patients: The relationship between mood and glycemic control. Journal of Diabetes and its Complications. 2005. March;19(2):113–22. doi:
    1. Schram M, Baan C, Pouwer F. Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium. Current Diabetes Reviews. 2009. May 1;5(2):112–9. doi:
    1. Lin EHB, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ, et al. Depression and Increased Mortality in Diabetes: Unexpected Causes of Death. The Annals of Family Medicine. 2009. September 1;7(5):414–21. doi:
    1. Kulzer B, Albus C, Herpertz S, Kruse J, Lange K, Lederbogen F, et al. Psychosoziales und Diabetes (Teil 1)—S2-Leitlinie Psychosoziales und Diabetes—Langfassung [Psychosocial Aspects of Diabetes Mellitus (Part 1)—S2-Guideline Psychosocial Aspects of Diabetes—Long Version]. Diabetologie und Stoffwechsel. 2013. June 18;8(03):198–242. German.
    1. Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016. December;39(12):2126–40. doi:
    1. van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. General Hospital Psychiatry. 2010. July;32(4):380–95. doi:
    1. Petrak F, Baumeister H, Skinner TC, Brown A, Holt RIG. Depression and diabetes: treatment and health-care delivery. The Lancet Diabetes & Endocrinology. 2015. June;3(6):472–85.
    1. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabetic Medicine. 2005. March;22(3):293–300. doi:
    1. Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diabetes Care. 1999. March 1;22(3):448–52.
    1. Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, et al. Behavioral and Clinical Factors Associated With Depression Among Individuals With Diabetes. Diabetes Care. 2004. April 1;27(4):914–20.
    1. Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N. How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Diabetic Medicine. 2016. June;33(6):835–43. doi:
    1. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale. Diabetes Care. 2005. March 1;28(3):626–31.
    1. Tsujii S, Hayashino Y, Ishii H, the Diabetes Distress and Care Registry at Tenri Study Group. Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with Type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 1): Diabetes distress associated with glycaemic control in a Japanese registry. Diabetic Medicine. 2012. November;29(11):1451–5. doi:
    1. Lloyd CE, Pambianco G, Orchard TJ. Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with Type 1 diabetes? Diabetic Medicine. 2010. February;27(2):234–7. doi:
    1. Reddy J, Wilhelm K, Campbell L. Putting PAID to Diabetes-Related Distress: The Potential Utility of the Problem Areas in Diabetes (PAID) Scale in Patients with Diabetes. Psychosomatics. 2013. January;54(1):44–51. doi:
    1. Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, et al. The Effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for Patients With Diabetes and Subclinical Depression: Results of a Randomized Controlled Trial. Diabetes Care. 2015. January 20;dc141416.
    1. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995. June;18(6):754–60.
    1. Hautzinger, M., Bailer, M., Hofmeister, D., Keller, F. Allgemeine Depressionsskala (ADS). Manual (2., überarbeitete und neu normierte Auflage) [Center for Epidemiological Studies Depression Scale—German version with new Norms] [Internet]. 2nd ed. Göttingen: Hogrefe; 2012 [cited 2016 Oct 26]. Available from: . German.
    1. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology. 1991;59(1):12–9.
    1. Evans C, Margison F, Barkham M. The contribution of reliable and clinically significant change methods to evidence-based mental health. Evidence-Based Mental Health. 1998. August 1;1(3):70–2.
    1. Burns RJ, Deschênes SS, Schmitz N. Cyclical relationship between depressive symptoms and diabetes distress in people with Type 2 diabetes mellitus: results from the Montreal Evaluation of Diabetes Treatment Cohort Study. Diabetic Medicine. 2015. October;32(10):1272–8. doi:
    1. Ehrmann D, Kulzer B, Haak T, Hermanns N. Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence. Diabetic Medicine. 2015. October;32(10):1264–71. doi:
    1. Pibernik-Okanovic M, Begic D, Peros K, Szabo S, Metelko Z, European Depression in Diabetes Research Consortium. Psychosocial factors contributing to persistent depressive symptoms in type 2 diabetic patients: a Croatian survey from the European Depression in Diabetes Research Consortium. J Diabetes Complicat. 2008. August;22(4):246–53. doi:
    1. Fisher L, Hessler DM, Polonsky WH, Mullan J. When Is Diabetes Distress Clinically Meaningful?: Establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012. February 1;35(2):259–64. doi:
    1. Sperl-Hillen J, Beaton S, Fernandes O, Von Worley A, Vazquez-Benitez G, Hanson A, et al. Are benefits from diabetes self-management education sustained? Am J Manag Care. 2013. February;19(2):104–12.
    1. Fonda SJ, McMahon GT, Gomes HE, Hickson S, Conlin PR. Changes in Diabetes Distress Related to Participation in an Internet-Based Diabetes Care Management Program and Glycemic Control. J Diabetes Sci Technol. 2009. January;3(1):117–24. doi:
    1. Charles ST, Reynolds CA, Gatz M. Age-related differences and change in positive and negative affect over 23 years. Journal of Personality and Social Psychology. 2001;80(1):136–51.
    1. Neupert SD, Almeida DM, Charles ST. Age Differences in Reactivity to Daily Stressors: The Role of Personal Control. J Gerontol B Psychol Sci Soc Sci. 2007. January 7;62(4):P216–25.
    1. Judd LL, Akiskal HS. The Clinical and Public Health Relevance of Current Research on Subthreshold Depressive Symptoms to Elderly Patients. The American Journal of Geriatric Psychiatry. 2002. May;10(3):233–8.
    1. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Predicting response to cognitive behavior therapy of depression in type 2 diabetes. General Hospital Psychiatry. 1998. September;20(5):302–6.
    1. Nolen-Hoeksema S. Gender Differences in Depression. Current Directions in Psychological Science. 2001. October;10(5):173–6.
    1. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al. Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale. Diabetes Care. 2005. March 1;28(3):626–31.
    1. Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes & Endocrinology. 2015. June;3(6):450–60.
    1. Nobis S, Lehr D, Ebert DD, Baumeister H, Snoek F, Riper H, et al. Efficacy of a Web-Based Intervention With Mobile Phone Support in Treating Depressive Symptoms in Adults With Type 1 and Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2015. May;38(5):776–83. doi:
    1. Rondags SMPA, de Wit M, Twisk JW, Snoek FJ. Effectiveness of HypoAware, a Brief Partly Web-Based Psychoeducational Intervention for Adults With Type 1 and Insulin-Treated Type 2 Diabetes and Problematic Hypoglycemia: A Cluster Randomized Controlled Trial. Diabetes Care. 2016. December;39(12):2190–6. doi:

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅